Stay updated on Dinutuximab and Irinotecan vs Irinotecan in SCLC Clinical Trial
Sign up to get notified when there's something new on the Dinutuximab and Irinotecan vs Irinotecan in SCLC Clinical Trial page.

Latest updates to the Dinutuximab and Irinotecan vs Irinotecan in SCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check19 days agoChange DetectedRegional rebranding: 'Rhône-Alpes' locations are replaced with 'Auvergne-Rhône-Alpes' equivalents, updating the area qualifier for the listed towns.SummaryDifference4%

- Check26 days agoChange Detected- Added a new version label (v3.2.0). - Removed the resource entry for small cell lung carcinoma under Genetic and Rare Diseases Information Center (GARD).SummaryDifference0.3%

- Check41 days agoChange Detected- The page now shows Revision: v3.0.2 (updated from v3.0.1). - The old Revision: v3.0.1 tag was removed. - The 'Back to Top' link was removed.SummaryDifference0.1%

- Check48 days agoChange DetectedRevision updated from v3.0.0 to v3.0.1 and a 'Back to Top' link was added. The core content and key data appear unchanged.SummaryDifference0.1%

- Check55 days agoChange DetectedThe web page has undergone significant updates, including the addition of numerous facility names and locations across various countries, particularly in Europe and Asia, as well as the inclusion of specific medical terms related to cancer treatment. Notably, the previous version's references to certain locations and medical topics have been removed.SummaryDifference30%

- Check77 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.0%

Stay in the know with updates to Dinutuximab and Irinotecan vs Irinotecan in SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dinutuximab and Irinotecan vs Irinotecan in SCLC Clinical Trial page.